How Biotechs Are Using Digital Twins for Clinical Trials

Episode 16 of Biotech Business with Fexingo explores how biotech startups are using digital twins—high-fidelity computer models of patients—to design and simulate clinical trials before enrolling a single human. Lucas and Luna break down the real-world example of a mid-stage oncology trial at a company called Unlearn.AI, where a digital twin control arm reduced the number of placebo patients needed by 40 percent, saving months and millions of dollars. They also discuss the regulatory hurdles: the FDA has accepted digital twin data in two investigational new drug applications so far in 2026, but questions remain about generalizability and bias. Tune in for a concrete look at how simulation is reshaping evidence generation in life sciences. #DigitalTwins #ClinicalTrials #Biotech #UnlearnAI #FDA #DrugDevelopment #AIinHealthcare #PatientSimulation #Oncology #ClinicalData #RegulatoryScience #BiotechStartups #LifeSciences #TrialDesign #PlaceboControl #FexingoBusiness #BusinessPodcast #BusinessAndTechnology Keep every episode free: buymeacoffee.com/fexingo